Development of mucus-penetrating antibiotic and quorum sensing inhibitor nanoparticle complex for bronchiectasis therapy
Bronchiectasis is a chronic respiratory disease characterized by permanent and irreversible dilatation of the airways caused by a vicious cycle of infection and inflammation, leading to the loss of lung function, morbidity, and mortality. Early results suggested inhaled ciprofloxacin (CIP) as a prom...
Saved in:
主要作者: | Tran, The Thien |
---|---|
其他作者: | Kunn Hadinoto Ong |
格式: | Thesis-Doctor of Philosophy |
語言: | English |
出版: |
Nanyang Technological University
2020
|
主題: | |
在線閱讀: | https://hdl.handle.net/10356/145374 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
相似書籍
-
A potential quorum-sensing inhibitor for bronchiectasis therapy: quercetin–chitosan nanoparticle complex exhibiting superior inhibition of biofilm formation and swimming motility of Pseudomonas aeruginosa to the native quercetin
由: Tran, The-Thien, et al.
出版: (2021) -
Ternary nanoparticle complex of antibiotic, polyelectrolyte, and mucolytic enzyme as a potential antibiotic delivery system in bronchiectasis therapy
由: Tran, The-Thien, et al.
出版: (2022) -
Development of inhalable antimicrobial nanoparticle complex
由: Yu, Hong
出版: (2018) -
An evaluation of inhaled antibiotic liposome versus antibiotic nanoplex in controlling infection in bronchiectasis
由: Tran, The-Thien, et al.
出版: (2020) -
Engineered antibiotic nanoparticles for inhaled anti-biofilm therapy
由: Cheow, Wean Sin
出版: (2012)